What is the appropriate treatment for costochondritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Costochondritis

Start with NSAIDs at maximum tolerated dosage as first-line therapy, evaluating response after 2-4 weeks, and reserve local corticosteroid injections for persistent focal pain that fails to respond to adequate NSAID therapy. 1

First-Line Pharmacological Management

The cornerstone of costochondritis treatment is NSAID therapy, with specific dosing recommendations based on guideline evidence:

  • Naproxen 375-1100 mg daily in two divided doses 1
  • Ibuprofen 1800 mg daily in divided doses 1
  • Diclofenac starting at 150 mg daily, with maintenance dosing of 75-100 mg daily 1
  • Celecoxib 200-400 mg daily for patients with gastrointestinal risk factors 1

Use oral NSAIDs at the lowest effective dose for the shortest possible period to minimize systemic risks, and consider topical NSAIDs to reduce systemic side effects. 1

Alternative and Adjunctive Pharmacological Options

When NSAIDs are insufficient, contraindicated, or poorly tolerated:

  • Regular dosing of acetaminophen (paracetamol) may be needed as an alternative or adjunct for pain relief. 1
  • For patients with increased gastrointestinal risk, use non-selective NSAIDs plus a gastroprotective agent, or a selective COX-2 inhibitor (which reduces serious GI risk with RR 0.18,95% CI: 0.14-0.23). 1

Second-Line Interventions for Refractory Cases

If inadequate response occurs after 2-4 weeks of NSAID therapy:

  • Consider switching to a different NSAID or adding acetaminophen 1
  • Local corticosteroid injections directed to the specific costochondral junction may be considered for persistent focal pain despite adequate NSAID therapy. 1
  • Short courses of oral prednisolone may be considered as bridging options while awaiting the effect of other agents. 1

Avoid long-term use of systemic glucocorticoids due to lack of evidence supporting their use for axial pain and significant adverse effect profile. 1

Non-Pharmacological Interventions

These should be integrated into the treatment plan from the outset:

  • Apply local heat or cold applications to the affected area. 1
  • Regular exercise and physical therapy should be considered as part of comprehensive treatment. 1
  • Provide patient education about the condition and lifestyle recommendations. 1
  • Temporary rest of the affected area during the acute phase is recommended. 1

Physical therapy utilizing manual therapy and therapeutic exercise targeting the cervicothoracic spine and ribcage may facilitate resolution, particularly in cases lasting several months. 2

Critical Safety Considerations and Contraindications

Before initiating NSAID therapy, identify absolute contraindications:

  • Patients with active peptic ulcer disease, severe renal impairment, or recent cardiovascular events should avoid NSAID therapy due to increased risk of gastrointestinal, renal, and cardiovascular toxicity. 1
  • Monitor for gastrointestinal, liver, and cardiorenal toxicity with prolonged NSAID use, particularly in elderly patients and those with comorbidities. 1

Common Pitfalls to Avoid

  • Do not use long-term systemic corticosteroids, which lack evidence and carry significant adverse effects. 1
  • Rule out serious causes of chest pain before diagnosing costochondritis, as it is often a diagnosis of exclusion—coronary artery disease is present in 3-6% of adult patients with chest pain and chest wall tenderness. 3
  • Consider infectious costochondritis in patients with diabetes, immunosuppression, or signs of systemic infection, as this requires debridement and antimicrobial therapy rather than NSAIDs alone. 4

References

Guideline

Costochondritis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

IMPAIRMENT BASED EXAMINATION AND TREATMENT OF COSTOCHONDRITIS: A CASE SERIES.

International journal of sports physical therapy, 2017

Research

Costochondritis: diagnosis and treatment.

American family physician, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.